IXAQF.OTC.PinkIx Acquisition CORP

DEF 14A: IX Acquisition Corp. Seeks Shareholder Approval for Third Extension to Complete Business Combination

Sentiment:

Proxy Statement


IX Acquisition Corp. is requesting shareholder approval for a third extension to the deadline for completing a business combination, aiming to extend the period to October 12, 2025.

Delay expectedThe company is seeking a third extension to the deadline for completing a business combination, indicating a delay in finding a suitable target.
Worse than expectedThe company is seeking a third extension to complete a business combination, indicating that it has not yet found a suitable target within the initial timeframe.The sponsor's contribution per share for the third extension could be less than the amount shareholders would receive in connection with the second extension.The company may be forced to liquidate if the extension is not approved, resulting in warrants expiring worthless.

Summary

  • IX Acquisition Corp. is seeking shareholder approval for a third extension to the deadline for completing a business combination.
  • The company's extraordinary general meeting is scheduled for October 9, 2024, to vote on the extension and other proposals.
  • Proposal One involves amending the company's memorandum and articles of association to allow the board to extend the business combination deadline from October 12, 2024, to October 12, 2025, on a monthly basis.
  • Proposal Two seeks ratification of Marcum LLP as the company's independent registered public accounting firm for the year ending December 31, 2024.
  • Proposal Three is to adjourn the meeting if necessary to solicit additional proxies.
  • The company's initial public offering (IPO) was consummated on October 12, 2021, with an initial deadline of April 12, 2023, to complete a business combination.
  • Previous extensions were approved, with the sponsor contributing funds to the trust account for each monthly extension.
  • If the third extension is approved, the sponsor will contribute the lesser of $50,000 or $0.03 per public share monthly as a loan to the company.
  • Shareholders have the right to redeem their public shares upon approval of the third extension amendment proposal.
  • As of September 20, 2024, the pro rata portion of funds available in the trust account for redemption was approximately $11.54 per public share.
  • The closing price of the Class A Ordinary Shares on September 20, 2024, was $11.4704.
  • If the third extension amendment proposal is not approved, the company will liquidate and dissolve.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the need for a third extension, indicating challenges in finding a suitable business combination target. The potential for liquidation and the reduced contribution per share also contribute to the lower sentiment.

Positives

  • The third extension provides additional time to complete a business combination, potentially benefiting shareholders.
  • Shareholders retain the right to redeem their shares if they do not wish to participate in the extended period.
  • The sponsor's contribution of funds to the trust account provides additional capital for the company.
  • The board believes that completing a business combination is in the best interests of the shareholders.

Negatives

  • If the third extension is not approved, the company will be forced to liquidate, and warrants will expire worthless.
  • The amount deposited per Public Share for the Third Extension from October 12, 2024 to October 12, 2025 could be less than the per share amount Public Shareholders would receive in connection with the Second Extension from April 12, 2024 to October 12, 2024 if the Third Extension Amendment Proposal were not approved.
  • Redemption of shares will reduce the amount in the trust account, potentially impacting the company's ability to complete a business combination.
  • There is no guarantee that a business combination will be completed even with the extension.

Risks

  • There is no assurance that the third extension will enable the company to complete a business combination.
  • Redemptions could leave the company with insufficient cash to consummate a business combination.
  • The market price of the company's shares may be volatile.
  • The company could be deemed an investment company, requiring burdensome compliance requirements and potentially leading to liquidation.
  • Regulatory authorities may not approve a proposed business combination.
  • If the company's securities are delisted from Nasdaq, investors' ability to make transactions in its securities could be limited.

Future Outlook

The company intends to continue working to consummate a business combination by the Third Extended Date if the Third Extension Amendment Proposal is approved.

Management Comments

  • The Board believes that shareholders should have an opportunity to evaluate the Business Combination and that our shareholders will benefit from the Company consummating the Business Combination.
  • The Board recommends that our shareholders vote FOR the Third Extension Amendment Proposal, FOR the Auditor Ratification Proposal and FOR the Adjournment Proposal, if presented.

Industry Context

This announcement is typical for SPACs approaching their initial business combination deadline, as they often seek extensions to continue their search for a suitable target.

Comparison to Industry Standards

  • SPACs like IX Acquisition Corp. typically have a lifespan of 18-24 months to complete a business combination, with options for extensions.
  • Sponsor contributions to the trust account during extension periods are a common practice to incentivize shareholders to remain invested.
  • Redemption rights are standard for SPAC shareholders when significant changes are proposed, such as extending the business combination deadline.
  • Comparable companies include other SPACs that have sought extensions, such as Gores Metropoulos II, Inc. and Churchill Capital Corp IV, although the specific terms of their extensions may vary.

Related Party Transactions

  • The Sponsor, IX Acquisition Sponsor LLC, will deposit funds into the Trust Account for each month of the Second Extension.
  • The Sponsor, Cantor Fitzgerald & Co. and Odeon Capital Group, LLC own an aggregate of 7,150,000 warrants (the Private Placement Warrants), which were purchased in a private placement that occurred simultaneously with the completion of the IPO (the Private Placement).

Stakeholder Impact

  • Shareholders have the right to redeem their shares if they do not wish to participate in the extended period.
  • If the company liquidates, warrant holders will not receive any liquidating distributions.
  • The Sponsor and the Company's officers and directors will not receive any monies held in the Trust Account as a result of their ownership of the Founder Shares or the Private Placement Warrants in the event of liquidation.

Next Steps

  • Shareholders will vote on the Third Extension Amendment Proposal, the Auditor Ratification Proposal, and the Adjournment Proposal at the Meeting on October 9, 2024.
  • If the Third Extension Amendment Proposal is approved, the Company will continue to seek a Business Combination by the Third Extended Date.
  • If the Third Extension Amendment Proposal is not approved, the Company will liquidate and dissolve.

Key Dates

DateDescription
March 1, 2021IX Acquisition Corp. incorporated as a Cayman Islands exempted company.
October 6, 2021Date of the investment management trust agreement between the Company and Continental Stock Transfer & Trust Company.
October 8, 2021Filing date of the Company's final prospectus in connection with the IPO.
October 12, 2021Consummation of the Company's initial public offering (IPO).
October 12, 2021Sponsor transferred an aggregate of 1,747,879 Founder Shares to certain investors for their purchase of a specified amount of Units in the IPO.
April 12, 2023Original deadline for the Company to complete a Business Combination (18 months after IPO).
April 10, 2023Shareholders approved an amendment to extend the deadline to May 12, 2023, and allow further extensions.
May 9, 2023Sponsor elected to convert 4,002,121 Founder Shares from Class B to Class A Ordinary Shares.
November 13, 2023Company instructed the trustee to liquidate the investments held in the Trust Account.
November 24, 2023Date of the Second 2023 Extraordinary Meeting of shareholders.
December 6, 2023Supplement to the Second 2023 Extraordinary Meeting of shareholders.
December 11, 2023The Company held an extraordinary general meeting of shareholders in lieu of an annual general meeting of shareholders.
September 16, 2024Record date for determining shareholders entitled to receive notice of and vote at the Meeting.
September 19, 2024Board fixed the close of business as the date for determining the shareholders entitled to receive notice of and vote at the Meeting and any adjournment thereof.
September 20, 2024Date of the redemption price per share was approximately $11.54.
September 20, 2024Closing price of the Class A Ordinary Shares on the Nasdaq Global Market was $11.4707.
September 23, 2024Date of the Proxy Statement.
September 24, 2024Date the Proxy Statement is first being mailed to shareholders.
October 7, 2024Deadline for shareholders to tender their shares for redemption (two business days prior to the Meeting).
October 8, 2024Deadline to submit your proxy online at www.cstproxyvote.com, 24 hours a day, 7 days a week, until 11:59 p.m., Eastern time.
October 9, 2024Date of the extraordinary general meeting in lieu of an annual general meeting of shareholders.
October 12, 2024Current deadline for the Company to consummate a Business Combination (Second Extended Date).
October 12, 2025Proposed new deadline for the Company to consummate a Business Combination (Third Extended Date).
November 12, 2024Commencement date for monthly contributions by the Sponsor if the Third Extension Amendment Proposal is approved.

Keywords

business combination, extension, redemption, shareholders, liquidation, trust account, sponsor, ordinary shares, amendment, proxy, vote, meeting, IPO, Marcum

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.